Carlos A Molina Selected Research

Carlos A Molina Research Topics

Disease

136	Stroke (Strokes) 05/2024 - 06/2002
71	Ischemic Stroke 05/2024 - 04/2003
21	Hemorrhage 01/2024 - 02/2003
20	Transient Ischemic Attack 10/2022 - 10/2003
17	Infarction (Infarctions) 01/2021 - 06/2002
13	Cerebral Hemorrhage 05/2024 - 07/2003
10	Embolic Stroke 01/2022 - 02/2004
9	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 09/2004
9	Myocardial Infarction 10/2019 - 06/2008
8	Atrial Fibrillation 05/2024 - 08/2008
8	Brain Ischemia (Cerebral Ischemia) 10/2019 - 02/2003
6	Pathologic Constriction (Stenosis) 12/2020 - 01/2005
5	Thrombosis (Thrombus) 01/2024 - 03/2007
5	Cerebral Infarction 01/2023 - 01/2013
4	Hematoma 05/2024 - 03/2009
4	Arterial Occlusive Diseases (Arterial Occlusive Disease) 04/2024 - 05/2010
4	Diabetes Mellitus 11/2019 - 05/2003
4	Hemorrhagic Stroke 09/2017 - 06/2006
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2015 - 07/2005
4	Ischemia 12/2011 - 02/2003
3	Hypertension (High Blood Pressure) 03/2024 - 01/2007
3	Atherosclerosis 12/2020 - 12/2007
3	Neoplasms (Cancer) 09/2013 - 11/2002
3	Brain Injuries (Brain Injury) 12/2010 - 07/2005
3	Inflammation (Inflammations) 12/2010 - 07/2007
3	Hyperglycemia 09/2007 - 05/2003
2	Neurologic Manifestations (Neurological Manifestations) 05/2024 - 11/2020
2	COVID-19 02/2024 - 11/2020
2	Brain Infarction 01/2024 - 09/2017
2	Intracranial Thrombosis (Cerebral Thrombosis) 01/2023 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2022 - 09/2013
2	Ganglion Cysts (Ganglion) 08/2019 - 01/2019
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 03/2012 - 01/2012
1	Rare Diseases (Rare Disease) 05/2024
1	Tobacco Use Disorder (Nicotine Dependence) 03/2024
1	Dyslipidemias (Dyslipidemia) 03/2024
1	Alcoholism (Alcohol Abuse) 03/2024
1	Factor XI Deficiency (Hemophilia C) 01/2024
1	Cardiomyopathies (Cardiomyopathy) 04/2022

Drug/Important Bio-Agent (IBA)

52	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2024 - 06/2002
21	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 12/2015
18	TicagrelorIBA 01/2023 - 12/2015
8	Biomarkers (Surrogate Marker)IBA 04/2022 - 08/2008
7	Proteins (Proteins, Gene)FDA Link 04/2022 - 07/2003
7	Matrix Metalloproteinases (MMPs)IBA 03/2012 - 02/2003
6	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 05/2003
5	Cytidine Triphosphate (CTP)IBA 01/2023 - 01/2017
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2019 - 03/2007
4	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2006 - 02/2003
3	Hemostatics (Antihemorrhagics)IBA 05/2024 - 09/2012
3	Factor XIa (Coagulation Factor XIa)IBA 01/2024 - 10/2022
3	EnzymesIBA 12/2022 - 04/2003
3	Thrombin FDA Link 01/2022 - 04/2003
3	AnticoagulantsIBA 01/2022 - 11/2017
3	C-Reactive ProteinIBA 05/2008 - 10/2003
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2024 - 10/2022
2	milvexianIBA 01/2024 - 10/2022
2	Neuroprotective AgentsIBA 01/2023 - 01/2021
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2022 - 12/2015
2	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 10/2021
2	RivaroxabanIBA 11/2019 - 01/2019
2	Vitamin K FDA Link 11/2019 - 11/2015
2	salicylhydroxamic acid (SHAM)IBA 08/2019 - 01/2019
2	boldenone undecylenate (Equipoise)IBA 01/2019 - 12/2010
2	UbiquitinIBA 02/2012 - 06/2008
2	Ligases (Synthetase)IBA 02/2012 - 12/2010
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2012 - 12/2011
2	danaparoid (Orgaran)FDA Link 12/2007 - 02/2004
2	Plasminogen Activator Inhibitor 1IBA 09/2004 - 06/2004
2	ImmunosorbentsIBA 07/2003 - 04/2003
1	PRT064445IBA 05/2024
1	eculizumab FDA Link 05/2024
1	Factor Xa InhibitorsIBA 05/2024
1	2,2,4,4-tetramethylpiperdine-1-oxylIBA 04/2024
1	Tenecteplase FDA Link 04/2024
1	CholesterolIBA 03/2024
1	Antihypertensive Agents (Antihypertensives)IBA 02/2024
1	Immunoglobulin FragmentsIBA 02/2024
1	Glycoproteins (Glycoprotein)IBA 02/2024
1	platelet membrane glycoprotein VIIBA 02/2024
1	glenzocimabIBA 02/2024
1	Toll-Like Receptor 4IBA 01/2023
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 12/2022
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 12/2022
1	Angiopoietin-2IBA 01/2022
1	Dabigatran FDA Link 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Troponin T (Troponin T1)IBA 01/2022

Therapy/Procedure

52	Therapeutics 05/2024 - 01/2003
28	Thrombectomy 02/2024 - 01/2014
10	Time-to-Treatment 09/2014 - 09/2004
7	Thrombolytic Therapy 01/2019 - 07/2005
6	Endovascular Procedures 01/2023 - 01/2013
4	Aftercare (After-Treatment) 05/2017 - 01/2007
3	Secondary Prevention 08/2023 - 08/2008
3	Stents 01/2021 - 11/2006
2	Contraindications 08/2019 - 01/2014
2	Punctures 03/2018 - 05/2013
2	Length of Stay 05/2017 - 05/2015
2	Microbubbles 10/2008 - 02/2006